Our present study has demonstrated that tumorous IRE1α significantly potentiated anti-tumor immunity in response to ER stress, which was highly associated with increased expression and secretion of pro-inflammatory cytokines and chemokines triggered by XBP1 and NF-κB downstream of IRE1α. The gene discussed is ERN1; the disease is neoplasm.